Considering the role of hypoxia in inducing resistance to anti-cancer agents, Weiler et al. (264) hypothesized that NDRG1 may mediate this hypoxia-induced resistance to TMZ by associating with methyltransferases such as MGMT. Here, NDRG1 is linked to cancer.